Douglas F. Easton
Impact in
- Genetics top 0.01%
- BRCA gene mutations in cancer
- Genomic variations and chromosomal abnormalities
- Genetic Associations and Epidemiology
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Genetics 245
- BRCA gene mutations in cancer 173
- Genetic Associations and Epidemiology 76
- Genomic variations and chromosomal abnormalities 39
-
- DNA Repair Mechanisms 42
- Co-authors
- Deborah Ford (15 shared papers)Antonis C. Antoniou (57 shared papers)Paul D.P. Pharoah (82 shared papers)D. Timothy Bishop (12 shared papers)Deborah J. Thompson (32 shared papers)Bruce A.J. Ponder (31 shared papers)Julian Peto (14 shared papers)Alison M. Dunning (61 shared papers)
- Journals
- British Journal of Cancer (25 papers)Cancer Epidemiology Biomarkers & Prevention (19 papers)Cancer Research (18 papers)Nature Genetics (16 papers)The American Journal of Human Genetics (14 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Douglas F. Easton
351 papers receiving 32.9k citations
Douglas F. Easton's Hit Papers
Peers
Comparison fields: 5 of 179
- Genetics 16.9k
- Cancer Research 8.0k
- Pathology and Forensic Medicine 6.2k
- Oncology 8.8k
- Reproductive Medicine 2.5k
Countries citing papers authored by Douglas F. Easton
This map shows the geographic impact of Douglas F. Easton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas F. Easton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas F. Easton more than expected).
Fields of papers citing papers by Douglas F. Easton
This network shows the impact of papers produced by Douglas F. Easton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas F. Easton. The network helps show where Douglas F. Easton may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas F. Easton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 358 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease Hit paper breakdown → | 2004 | 1902 |
| 2 | Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Hit paper breakdown → | 1995 | 1239 |
| 3 | Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Hit paper breakdown → | 1993 | 996 |
| 4 | Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) Hit paper breakdown → | 2005 | 765 |
| 5 | Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands Hit paper breakdown → | 1994 | 764 |
| 6 | PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Hit paper breakdown → | 2006 | 689 |
| 7 | The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2 Hit paper breakdown → | 2002 | 614 |
| 8 | Polygenic susceptibility to breast cancer and implications for prevention Hit paper breakdown → | 2002 | 590 |
| 9 | Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results Hit paper breakdown → | 2008 | 582 |
| 10 | Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk Hit paper breakdown → | 2015 | 579 |
| 11 | Risk of lymphoedema following the treatment of breast cancer Hit paper breakdown → | 1986 | 562 |
| 12 | Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles Hit paper breakdown → | 2006 | 513 |
| 13 | ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Hit paper breakdown → | 2006 | 511 |
| 14 | Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. | 1995 | 408 |
| 15 | 2004 | 395 | |
| 16 | BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors Hit paper breakdown → | 2019 | 386 |
| 17 | 2005 | 377 | |
| 18 | 2008 | 366 | |
| 19 | 1987 | 350 | |
| 20 | 1986 | 343 |
About Douglas F. Easton
Douglas F. Easton is a scholar working on Genetics, Molecular Biology, Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 358 papers that have together received 33.9k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (173 papers), Genetic Associations and Epidemiology (76 papers), Genetic factors in colorectal cancer (60 papers), Cancer Genomics and Diagnostics (51 papers), DNA Repair Mechanisms (42 papers), Genomic variations and chromosomal abnormalities (39 papers), Global Cancer Incidence and Screening (31 papers) and Ovarian cancer diagnosis and treatment (25 papers). The work is most often cited by research in Genetics (16.9k citations), Cancer Research (8.0k citations), Pathology and Forensic Medicine (6.2k citations), Oncology (8.8k citations) and Reproductive Medicine (2.5k citations). Douglas F. Easton has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Deborah Ford, Antonis C. Antoniou, Paul D.P. Pharoah, D. Timothy Bishop, Deborah J. Thompson, Bruce A.J. Ponder, Julian Peto, Alison M. Dunning, Rosalind A. Eeles and Michael R. Stratton. Their work appears in journals such as British Journal of Cancer, Cancer Epidemiology Biomarkers & Prevention, Cancer Research, Nature Genetics and The American Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.